Crossmark

CTLA4-Ig treatment induces M1–M2 shift in cultured monocyte-derived macrophages from healthy subjects and rheumatoid arthritis patients

Published Online: 2021-12-24

Published Print: 2021-12

Authors

Cutolo, Maurizio http://orcid.org/0000-0002-5396-0932
Soldano, Stefano

Gotelli, Emanuele

Montagna, Paola

Campitiello, Rosanna

Paolino, Sabrina

Pizzorni, Carmen

Sulli, Alberto

Smith, Vanessa

Tardito, Samuele
Funding

Funding for this research was provided by:

bristol-myers squibb (IM101-811)
License Information

Text and Data Mining valid from 2021-12-01

Version of Record valid from 2021-12-24
More Information

Article History

Received: 26 July 2021

Accepted: 3 December 2021

First Online: 24 December 2021

Declarations

:

: The study was approved by the local Ethical Board Committee. The protocol ID is 2015-002729-21. All healthy subjects enrolled in the study gave signed informed consent.

: Not applicable

: M.C. received a grant provided by BMS for the present in vitro study (study ID: IM101-811). All other authors declared that they have no competing interests.

Document is current